key: cord-0764640-9ss2h3kb
authors: Praveen, S.; Soh, T.
title: Adherence to NHS England-BSTI radiology decision tool in suspected COVID-19 patients
date: 2020-12-31
journal: Clinical Radiology
DOI: 10.1016/j.crad.2020.11.053
sha: b010aaf1b7020cebdc62474a99a9014d39a90240
doc_id: 764640
cord_uid: 9ss2h3kb

nan

or fluoroscopic guidance usually to evaluate whether a lesion is infective or neoplastic in nature, so clinical management can be tailored accordingly. Our aim was to determine our diagnostic yield of spinal and pelvic biopsies in comparison to the literature. Standard: Diagnostic yield quoted in literature ranges between 32e43% for infection and 68e97% for neoplasm. Target: To achieve similar results to literature. Methodology: The first audit was performed between November 2014 to November 2016 and second audit between July 2017 to March 2019. The computerised radiology information system (CRIS) and electronic patient records (EPR) were used to obtain details of the biopsy and pathology results. Results of first audit round: 91 biopsies were performed; suspected neoplasm was the indication in 68 cases, infection in 19 and in four cases both were suspected. In 35% of suspected infection cases, the causative organism was identified. Diagnostic yield for neoplasm was 60%. First action plan: Our neoplasm yield was below literature standards. This could be due to our lower threshold for biopsy of indeterminate lesions and desire to obtain tissue diagnosis. Our aim was to re-audit and use better patient selection for spinal biopsies at the multidisciplinary team meeting (MDTM). Results of second audit round: 71 biopsies performed, 54 using CT guidance and 17 under fluoroscopy. Suspected infection was the indication in 32 cases, neoplasm in 37 and in two aetiology was unclear. In 33% of confirmed infection, the organism was isolated. Diagnostic yield for neoplasm was 59%. Second action plan: Our diagnostic yield for infection and neoplasm were similar in both audit cycles. The neoplasm yield remained slightly lower compared to the literature. In future, we aim to design a new mandatory clinical request form to include any relevant treatment, References: 

Category: Biopsies and FNA Background to the audit: The General Medical Council (GMC) and RCR require informed consent for procedures including liver biopsy. 1, 2 The 2008 UK audit of image-guided or image-assisted liver biopsy demonstrated complication rates of minor pain 1%, severe pain 10%, hypotension 0.75%, haemorrhage 0.4%, damage to adjacent organs 0.1% and death 0.1%. Standard: All consent forms for liver biopsy should document all the risks. Indicator: Percentage of consent forms which document all the risks. Target: 100% of consent forms will mention all risks. Methodology: Retrospective analysis was performed for all adult patients undergoing ultrasound-guided liver biopsy between December 2017 and August 2018 (first cycle) and May 2019 and January 2020 (second cycle) at the Queen Elizabeth University Hospital, Glasgow. Consent forms for 50 patients were obtained from the electronic patient notes and the radiology information system (RIS) for each cycle. Results of first audit round: No forms mentioned all the risks. The documented risks were infection 90%, pain 84%, bleeding 100%, damage to adjacent structure 58% and death 10%. First action plan: We designed a pre-printed, standardised consent form which documented the risks and their frequency. The results and the form were presented to the consultant body at a local audit meeting. Results of second audit round: Pre-printed consent forms were used in 90% of cases. Consequently, the target of all risks being documented was met. 10% of forms were handwritten. On these, the documented risks were infection 90%, pain 80%, bleeding 100%, damage to adjacent structure 60% and death 20%. 

Category: General Background to the audit: Chest radiographs are typically the firstline imaging modality used for patients with suspected COVID-19. 1 British Society of Thoracic Imaging (BSTI) and NHS England (NHSE) have released a COVID-19 radiology decision-support tool to aid clinicians on the optimal work-up of suspected COVID-19 patients. 2 This audit aims to review adherence to this guidance when healthcare staff suspect hospital inpatients of newly developed COVID-19 infections. Standard: According to the NHSE-BSTI decision-support tool: 1. Every patient suspected of COVID-19 and clinically deteriorating should have a chest X-ray requested along with their COVID-19 swab 2. Clinical deterioration is defined as oxygen saturations < 94% or <90% in patients with COPD or scoring at least 3 on the National Early Warning Score (NEWS). Indicator: Degree of compliance with the standard guidance. Target: 100% compliance. Methodology: A retrospective study design was performed using electronic health records to identify inpatients who received COVID-19 PCR tests. A predetermined exclusion criterion was strictly adhered to: 1. Patients who did not co-present with clinical deteriorations were excluded. Included records were assessed to determine if chest X-rays were ordered alongside the COVID-19 PCR tests. Results of first audit round: 149 patients audited. Wells' score was included in 58% of requests with D-dimer used appropriately in 25%. Overall 16% of referrals met NICE guidelines. The incidence of DVT was 16%. First action plan: New requesting software was introduced which mandated a Wells' score and D-dimer (if Wells' <2). Results of second audit round: 126 patients audited. Wells' score included in 68%, with appropriate D-dimer usage in 33%. Overall 52% referrals met NICE guidelines. The incidence of DVT was 17%. Second action plan: Implementation of improved requesting software led to a modest but insufficient improvement in referral quality. Technology alone cannot be relied upon to improve referral quality. Further improvement requires a multifaceted effort, working collaborative

Frequency and distribution of chest radiographic findings in COVID-19 positive patients

(last accessed 17/ 11/20) Lumber spine radiographer for chronic back pain audit Authors: R. Shamoon 1 , S. Kamath 2 References: 1

Does this patient have deep vein thrombosis?

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis